Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BT8009 |
Trade Name | |
Synonyms | BT-8009|BT 8009 |
Drug Descriptions |
BT8009 consists of a Nectin-4 binding bicyclic peptide linked to the toxin MMAE, which delivers the toxin to Nectin-4-expressing tumor cells, potentially resulting in tumor growth inhibition (PMID: 36112771). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C178397 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BT8009 | BT8009 | 0 | 2 |
BT8009 + Nivolumab | BT8009 Nivolumab | 0 | 0 |
BT8009 + Pembrolizumab | BT8009 Pembrolizumab | 0 | 2 |